Risk of Leaking heart valves with Fluoroquinolone class of antibiotics: Drug Safety Alert Health Canada

Drug Safety Alert, Global Safety Alerts, Health Canada, Medicinal Product Updates, Safety Communications, ,

Safety update: Potential Risk of leaking heart valves (heart valve regurgitation) associated with the use of antibiotics belonging to the Fluoroquinolone class which included ciprofloxacin-, levofloxacin-, moxifloxacin- and norfloxacin-containing medicinal products which are administered by injection or by mouth (systemic) and by breathing in (inhaled). Fluoroquinolones broader spectrum antibiotics which are used in the treatment…

Read More

An unfavourable benefit-risk profile for Ulipristal acetate 5 mg: A drug withdrawal story

Drug Safety Updates, Drug Withdrawal, EMA-European Medicines Agency, Global Safety Alerts, Health Canada, HSA-Singapore, Medicinal Product Updates, NPRA-Malaysia, Pharmacovigilance, PRAC, Risk Minimization Measures, Safety Communications, Voluntary ADR reporting, ,

Ulipristal acetate is a selective progesterone receptor modulator which acts by preventing the effects of the female progesterone hormone. This medicine is available in two brand names in market for the below two different therapeutic uses. Esmya® tablets comprising 5 mg ulipristal acetate and therapeutically indicated for Uterine fibroids. It is used for the treatment…

Read More

Health Canada Drug Safety updates-July-2020

Drug Safety Updates from Health Canada-July 2020

Drug Safety Updates, Global Safety Alerts, Health Canada, Medicinal Product Updates, Pharmacovigilance, Voluntary ADR reporting, , , ,

Health Canada has published new drug safety information to raise awareness to health care professionals and public about the below safety concern which recently made safety labelling changes for the product monograph. –Health Product Info Watch –July 2020. The safety topics discussed below in brief. Risk of cerebrovascular accidents with ibrutinib Severe 6-mercaptopurine toxicity associated…

Read More

Health Canada Drug Safety Updates_June 2020

Drug Safety Updates from Health Canada-June 2020

Drug Safety Updates, Global Safety Alerts, Health Canada, Medicinal Product Updates, Pharmacovigilance, Voluntary ADR reporting, , , , ,

Health Canada has published new drug safety information to raise awareness to health care professionals and public about the below safety concern which recently made safety labelling changes for the product monograph. –Health Product Info Watch –June 2020. The safety topics discussed below in brief. Pulmonary edema risk with amlodipine Risks of artery dissection and…

Read More

error: Content is protected !!